OBJECTIVE: To demonstrate the efficacy of core-needle biopsy to avoid unnecessary surgery; to assess the technical difficulties of this method; to establish decision criteria for clinical follow-up or surgery in patients with lesions classified as suspicious for malignancy (BI-RADS IV); to expedite surgery in patients with lesions classified as highly suspicious for malignancy (BI-RADS V). MATERIALS AND METHODS: The patients were submitted to clinical examination, mammography and ultrasound. Core-needle biopsy was done using a 14-gauge needle, and 4-8 cores per lesion were obtained. RESULTS: A hundred lesions were studied, 47 of them underwent surgery and biopsy, and 34 cancers were diagnosed. In 23 lesions classified as probably benign (III) only one case of cancer was diagnosed (4.34%). In 43 lesions classified as IV, seven (16.28%) cancers were found whereas in 34 lesions classified as V, 26 (76.47%) cases of cancer were identified. It was possible to avoid surgery in 53 cases (53%). Difficulties in core-needle biopsy occurred in seven cases including insufficient material, risk of malignancy due to sclerosing lesions and lack of correlation between imaging and core-needle biopsy results. All the core biopsy diagnoses of malignancy were confirmed by surgery. There was one false negative result when the core biopsy specimen examination showed atypical hyperplasia while surgery specimen analysis revealed a carcinoma. There were no false positive cases.

Keywords: Breast disease, Breast cancer, Core-needle biopsy, Breast ultrasound

Superior vena cava syndrome is defined by a set of signs and symptoms secondary to superior vena cava obstruction caused principally by malignant diseases. The present report describes the case of an unusual clinical manifestation of this syndrome with bilateral breast swelling, and emphasizes the relevance of knowledge on mammographic signs of systemic diseases.

Keywords: Mammography; Superior vena cava syndrome; Subclavian vein thrombosis.

OBJECTIVE: To present the current recommendations for breast cancer screening in Brazil, as devised by the Brazilian College of Radiology and Diagnostic Imaging, the Brazilian Breast Disease Society, and the Brazilian Federation of Gynecological and Obstetrical Associations. MATERIALS AND METHODS: We analyzed scientific studies available in the Medline and Lilacs databases. In the absence of evidence, the recommendations reflected the consensus of a panel of experts. RECOMMENDATIONS: Annual mammography screening is recommended for women 40–74 years of age. Among women ≥ 75 years of age, annual mammography screening should be reserved for those with an expected survival > 7 years. Complementary ultrasound should be considered for women with dense breasts. Complementary magnetic resonance imaging is recommended for women at high risk. When available, an advanced form of mammography known as tomosynthesis can be considered as a means of screening for breast cancer.

Keywords: Breast cancer screening; Mammography; Ultrasound; Magnetic resonance imaging.